IP Library Granted Patent US 8,563,718
Granted Patent B2
US 8,563,718 · App. 13/063,226 · Granted Oct 22, 2013

Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes

Inventors: John Robert Rizzo (Brownsburg, IN); Sathish Kumar Boini (West Lafayette, IN); Radhe Krishan Vaid (Westfield, IN)
Assignee: Eli Lilly and Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,563,718
App. No.
13/063,226
Granted
Oct 22, 2013
Kind
B2
Abstract

The present invention relates to a synthetic intermediate of the formula: and its use in a synthetic process to make compounds of the formula

Claims (35)

1. A compound of the formula

wherein:

R 1 and R 2 are independently ethyl or n-propyl;

or a salt thereof.

2. The compound according to claim 1 , or a salt thereof, wherein R 1 and R 2 are each ethyl.

3. A synthetic process for preparing a compound of the formula

wherein R 1 and R 2 are independently ethyl or n-propyl,

comprising the steps of

i) reacting a compound of the formula

or a salt thereof, with 2,4-di-chlorothiazole, or a salt thereof, in the presence of a copper halide catalyst, a ligand selected from 1,10-phenanthroline and bipyridine, and a base selected from K 3 PO 4 and Cs 2 CO 3 , in the presence of a suitable solvent, to form a compound of the formula

ii) reacting the product of step i), with morpholine, or a salt thereof, in the presence of a suitable inorganic base and solvent.

4. The process according to claim 3 wherein R 1 and R 2 are each ethyl.

5. The process according to claim 3 wherein the copper halide is CuCl.

6. The process according to claim 3 wherein the ligand is 1,10-phenanthroline.

7. The process according to claim 3 wherein the base in step i) is Cs 2 CO 3 .

8. The process according to claim 3 wherein the base in step ii) is K 2 CO 3 .

9. The process according to claim 3 wherein R 1 and R 2 are each ethyl, the copper halide is CuCl, the ligand is 1,10-phenanthroline, the base in step i) is Cs 2 CO 3 , and the base in step ii) is K 2 CO 3 .

10. The process according to claim 9 wherein the solvent for step i) is 1,4-Dioxane or 2-MeTHF/DMAC and the solvent for step ii) is morpholine, 2-MeTHF, or 2-propanol.

11. A synthetic process for preparing a compound of the formula

wherein R 1 and R 2 are independently ethyl or n-propyl,

comprising the steps of

i) reacting a compound of the formula

or a salt thereof, with excess morpholine or salt thereof, in the presence of a suitable solvent.

12. The process of claim 11 wherein the solvent is 2-methyl tetrahydrofuran.

13. The process of claim 11 wherein the solvent is 2-propanol.

14. The process of claim 11 wherein R 1 and R 2 are each ethyl.

15. A synthetic process for preparing a compound of the formula

wherein R 1 and R 2 are independently ethyl or n-propyl,

comprising the steps of

i) reacting a compound of the formula

or a salt thereof, with 2,4-di-chlorothiazole, or a salt thereof, in the presence of a copper halide catalyst, a ligand selected from 1,10-phenanthroline and bipyridine, and a base selected from K 3 PO 4 and Cs 2 CO 3 , to form a compound of the formula

ii) reacting the product of step i), with an excess of morpholine, or a salt thereof, in a suitable solvent.

16. The process of claim 15 wherein the solvent is 2-methyl tetrahydrofuran.

17. The process of claim 15 wherein the solvent is 2-propanol.

18. The process of claim 15 wherein R 1 and R 2 are each ethyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2011
From: RIZZO, JOHN ROBERT; BOINI, SATHISH KUMAR; VAID, RADHE KRISHAN
To: ELI LILLY AND COMPANY
Reel/Frame 025932/0486 →
Continuity (2)
Provisional Application 61102153 · Oct 2, 2008
Related Publication 20110166345A1 · Jul 7, 2011